McGuire DK, Shih WJ, Cosentino F, Charbonnel B, Cherney DZ, Dagogo-Jack S, et al
In April 2025, a research article demonstrated how GLP-1s might drive depression and suicidal ideation in people with a genetic predisposition toward low dopamine function
Some users find it helpful to rest their arm against a table or doorframe to stabilize the tissue
Dual- and triple-receptor agonists also offer the potential for the treatment of obesity (3941)
What Clients Are Telling Me about their experience with GLP-1s Client responses to GLP-1s vary widely: Some experience little to no appetite or weight changepossibly requiring dose adjustments
Earlier research and case reports also suggest a significant rise in NAION cases among patients treated with semaglutide and tirzepatide, with some reports indicating up to a fourfold increase in risk